Aimovig Pregnancy Exposure Registry (NCT06150781)

🧪 Interventions in This Study

• erenumab-aooe (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• IQVIA Virtual Site — Durham, North Carolina

📞 Contact the Study Coordinator

Phone: (866) 572-6436

Email: medinfo@amgen.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Migraine

• A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
• Treatment for Migraine and Mood — The Bronx, New York
• Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
• A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
• Migraine Manager (R01) — Cincinnati, Ohio
• Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey

Explore by condition: All Migraine clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.